143 related articles for article (PubMed ID: 8255684)
1. The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease.
Cotton RB; Olsson T; Law AB; Parker RA; Lindstrom DP; Silberberg AR; Sundell HW; Sandberg K
Pediatr Res; 1993 Oct; 34(4):495-501. PubMed ID: 8255684
[TBL] [Abstract][Full Text] [Related]
2. Lung mechanics and gas exchange in ventilated preterm infants during treatment of hyaline membrane disease with multiple doses of artificial surfactant (Exosurf).
Pfenninger J; Aebi C; Bachmann D; Wagner BP
Pediatr Pulmonol; 1992 Sep; 14(1):10-5. PubMed ID: 1437337
[TBL] [Abstract][Full Text] [Related]
3. Postnatal changes in pulmonary mechanics and energetics of infants with respiratory distress syndrome following surfactant treatment.
Bhutani VK; Bowen FW; Sivieri EM
Biol Neonate; 2005; 87(4):323-31. PubMed ID: 15985755
[TBL] [Abstract][Full Text] [Related]
4. Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.
Sehgal SS; Ewing CK; Richards T; Taeusch HW
J Natl Med Assoc; 1994 Jan; 86(1):46-52. PubMed ID: 8151722
[TBL] [Abstract][Full Text] [Related]
5. Surfactant replacement therapy improves ventilation inhomogeneity in infants with respiratory distress syndrome.
Sandberg KL; Lindstrom DP; Sjöqvist BA; Parker RA; Cotton RB
Pediatr Pulmonol; 1997 Nov; 24(5):337-43. PubMed ID: 9407567
[TBL] [Abstract][Full Text] [Related]
6. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country.
da Costa DE; Pai MG; Al Khusaiby SM
Pediatr Pulmonol; 1999 May; 27(5):312-7. PubMed ID: 10344709
[TBL] [Abstract][Full Text] [Related]
7. Surfactant therapy for hyaline membrane disease: the Chandigarh experience.
Narang A; Kumar P; Dutta S; Kumar R
Indian Pediatr; 2001 Jun; 38(6):640-6. PubMed ID: 11418729
[No Abstract] [Full Text] [Related]
8. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity.
Modanlou HD; Beharry K; Padilla G; Norris K; Safvati S; Aranda JV
J Perinatol; 1997; 17(6):455-60. PubMed ID: 9447532
[TBL] [Abstract][Full Text] [Related]
10. Exosurf versus Survanta surfactant preparations: proportional-hazards regression analysis of time to successful extubation and discontinuation of oxygen therapy.
Arnold C; Adams E; Torres E; Sidebottom R
J Perinatol; 1996; 16(1):9-14. PubMed ID: 8869533
[TBL] [Abstract][Full Text] [Related]
11. Respiratory mechanics before and after late artificial surfactant rescue.
Todd DA; Choukroun ML; Fayon M; Kays C; Guénard H; Galpérine I; Demarquez JL
J Paediatr Child Health; 1995 Dec; 31(6):532-6. PubMed ID: 8924306
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.
Choukroun ML; Llanas B; Apere H; Fayon M; Galperine RI; Guenard H; Demarquez JL
Pediatr Pulmonol; 1994 Nov; 18(5):273-8. PubMed ID: 7898964
[TBL] [Abstract][Full Text] [Related]
13. [Surfactant therapy in newborns with hyaline membrane disease].
Tsvetkova S; Chernookova V; Efremova R; Nedeva N; Bogdanova V
Akush Ginekol (Sofiia); 2000; 39 Suppl 2():12-4. PubMed ID: 11188005
[No Abstract] [Full Text] [Related]
14. Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation.
Malathi I; Ng KC
Ann Acad Med Singap; 1995 Nov; 24(6):781-4. PubMed ID: 8838980
[TBL] [Abstract][Full Text] [Related]
15. Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.
Stenson BJ; Glover RM; Parry GJ; Wilkie RA; Laing IA; Tarnow-Mordi WO
Arch Dis Child Fetal Neonatal Ed; 1994 Jan; 70(1):F19-24. PubMed ID: 8117122
[TBL] [Abstract][Full Text] [Related]
16. Functional residual capacity and compliance of the respiratory system after surfactant treatment in premature infants with severe respiratory distress syndrome.
Dinger J; Töpfer A; Schaller P; Schwarze R
Eur J Pediatr; 2002 Sep; 161(9):485-90. PubMed ID: 12200607
[TBL] [Abstract][Full Text] [Related]
17. Changes in pulmonary artery pressure during the acute phase of respiratory distress syndrome treated with three different types of surfactant.
Hamdan AH; Shaw NJ
Pediatr Pulmonol; 1998 Mar; 25(3):191-5. PubMed ID: 9556011
[TBL] [Abstract][Full Text] [Related]
18. [The effect of surfactant therapy on the oxygen treatment of premature infants with HMD].
Iarŭkova N
Akush Ginekol (Sofiia); 1998; 37(1):3-5. PubMed ID: 9770786
[TBL] [Abstract][Full Text] [Related]
19. Comparison of respiratory function and fluid balance in very low birthweight infants given artificial or natural surfactant or no surfactant treatment.
Kavvadia V; Greenough A; Dimitriou G; Forsling M
J Perinat Med; 1998; 26(6):469-74. PubMed ID: 10224604
[TBL] [Abstract][Full Text] [Related]
20. Surfactant therapy and high-frequency jet ventilation in the management of a piglet model of the meconium aspiration syndrome.
Wiswell TE; Peabody SS; Davis JM; Slayter MV; Bent RC; Merritt TA
Pediatr Res; 1994 Oct; 36(4):494-500. PubMed ID: 7816525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
